Literature DB >> 15160409

Sample size determination for comparing several survival curves with unequal allocations.

Susan Halabi1, Bahadur Singh.   

Abstract

Ahnn and Anderson derived sample size formulae for unstratified and stratified designs assuming equal allocation of subjects to three or more treatment groups. We generalize the sample size formulae to allow for unequal allocation. In addition, we define the overall probability of death to be equal to one minus the censored proportion for the stratified design. This definition also leads to a slightly different definition of the non-centrality parameter than that of Ahnn and Anderson for the stratified case. Assuming proportional hazards, sample sizes are determined for a prespecified power, significance level, hazard ratios, allocation of subjects to several treatment groups, and known censored proportion. In the proportional hazards setting, three cases are considered: (1) exponential failures--exponential censoring, (2) exponential failures--uniform censoring, and (3) Weibull failures (assuming same shape parameter for all groups)--uniform censoring. In all three cases of the unstratified case, it is assumed that the censoring distribution is the same for all of the treatment groups. For the stratified log-rank test, it is assumed the same censoring distribution across the treatment groups and the strata. Further, formulae have been developed to provide approximate powers for the test, based upon the first two or first four-moments of the asymptotic distribution. We observe the following two major findings based on the simulations. First, the simulated power of the log-rank test does not depend on the censoring mechanism. Second, for a significance level of 0.05 and power of 0.80, the required sample size n is independent of the censoring pattern. Moreover, there is very close agreement between the exact (asymptotic) and simulated powers when a sequence of alternatives is close to the null hypothesis. Two-moment and four-moment power series approximations also yield powers in close agreement with the exact (asymptotic) power. With unequal allocations, our simulations show that the empirical powers are consistently above the target value of prespecified power of 0.80 when 50 per cent of the patients are allocated to the treatment group with the smallest hazard. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160409     DOI: 10.1002/sim.1771

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome.

Authors:  Barry Kurt Moser; Susan Halabi
Journal:  Commun Stat Theory Methods       Date:  2015       Impact factor: 0.893

2.  Sample size and power for a logrank test and Cox proportional hazards model with multiple groups and strata, or a quantitative covariate with multiple strata.

Authors:  John M Lachin
Journal:  Stat Med       Date:  2013-05-13       Impact factor: 2.373

3.  Score and deviance residuals based on the full likelihood approach in survival analysis.

Authors:  Susan Halabi; Sandipan Dutta; Yuan Wu; Aiyi Liu
Journal:  Pharm Stat       Date:  2020-08-09       Impact factor: 1.894

4.  Group Sequential Survival Trial Design and Monitoring Using the Log-Rank Test.

Authors:  Jianrong Wu; Xiaoping Xiong
Journal:  Stat Biopharm Res       Date:  2017-03-02       Impact factor: 1.452

5.  On model specification and selection of the Cox proportional hazards model.

Authors:  Chen-Yen Lin; Susan Halabi
Journal:  Stat Med       Date:  2013-06-19       Impact factor: 2.373

6.  A sample size planning approach that considers both statistical significance and clinical significance.

Authors:  Bin Jia; Henry S Lynn
Journal:  Trials       Date:  2015-05-12       Impact factor: 2.279

7.  Comparison of regression imputation methods of baseline covariates that predict survival outcomes.

Authors:  Nicole Solomon; Yuliya Lokhnygina; Susan Halabi
Journal:  J Clin Transl Sci       Date:  2020-09-04

8.  A Retrospective Comparative Study on Median Time to Sputum Culture Conversion in Multi-Drug Resistant Pulmonary Tuberculosis Patients in Pastoral and Non-Pastoral Settings in Southeast Oromia, Ethiopia.

Authors:  Abebe Megerso; Negusie Deyessa; Godana Jarso; Alemayehu Worku
Journal:  Infect Drug Resist       Date:  2021-12-14       Impact factor: 4.003

9.  Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes.

Authors:  Lira Pi; Susan Halabi
Journal:  Diagn Progn Res       Date:  2018-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.